A Classical Approach to Venture Capital
Easton Capital is a leading Venture Capital Fund with a sector focus in healthcare and life sciences. Our professionals have decades of experience in all aspects of healthcare, providing unique financial, strategic, operational perspectives and resources to entrepreneurs who want to grow their business.
Our mission is to invest only in those opportunities that offer services or products that can materially improve the healthcare people receive or reduce its cost. In addition, we take a classical view of venture capital. Transactions must be structured to maximize potential returns and minimize risks in all economic environments. That philosophy translates into financing companies that have capital efficient business models (i.e., generally require no more than an additional $10-20 million to get to market and become cash flow positive or be acquired). We recognize that not all of our investments will succeed. However, our model means that when they do, they will generate significant multiples and when they don't, our losses will be minimized.
Our approach directly aligns our interests and goals with entrepreneurs and managers of the enterprises we support. Like them, we want to maximize returns, while minimizing risks, on the lowest reasonable capital base, insuring the least dilution.
Our strength as a venture capital firm derives from a deep well-seasoned team with a breadth of diverse experience in science, technology, clinical affairs, investment, operations, and business development. Team members have participated in running more than $1 billion in investment funds during their careers, have helped launch more than 100 companies, and have made more than five investments that each generated returns in excess of 100x-to-1.
Additionally, five of Easton's portfolio companies have been sold or are trading at values greater than $1 billion.
HIGH DIVERSITY IN MANAGEMENT TEAMS-40% OF THE CEO's OR FOUNDERS IN ITS LATEST FUND ARE WOMEN:
Easton prides itself on its reputation for thinking outside the box and focusing solely on the merits of the entrepreneurs and businesses it backs. Consequently, it is willing to support promising non-traditional CEO’s. Perhaps, as a result, it has attracted a disproportionate number of the most qualified female entrepreneurs seeking backing from a top tier venture fund. Thus, 40% of the Founders and/or CEO's in its most recent fund are women. In addition, three of its most successful investments during the last decade, Promedior, Conor MedSystems, and Acorda had a woman as the CEO or COO.